EUVIMEDEUVIMED entdecken
Open Access

Empowering personalized pharmacogenomics with generative AI solutions

Mullai Murugan iD, Bo Yuan, Eric Venner, Christie M Ballantyne, Katherine M Robinson, James C Coons, Liwen Wang, Philip E Empey, Richard A Gibbs

Journal of the American Medical Informatics Association · 20.05.2024 · 31 (6) · 1356-1366

DOI: 10.1093/jamia/ocae039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Medical Informatics Association, online erschienen am 06.03.2024. Verfasst von Mullai Murugan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, United States. Hauptthemen laut MEDLINE: Precision Medicine, Pharmacogenetics. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study evaluates an AI assistant developed using OpenAI’s GPT-4 for interpreting pharmacogenomic (PGx) testing results, aiming to improve decision-making and knowledge sharing in clinical genetics and to enhance patient care with equitable access. Materials and Methods The AI assistant employs retrieval-augmented generation (RAG), which combines retrieval and generative techniques, by harnessing a knowledge base (KB) that comprises data from the Clinical Pharmacogenetics Implementation Consortium (CPIC). It uses context-aware GPT-4 to generate tailored responses to user queries from this KB, further refined through prompt engineering and guardrails.

Results

Evaluated against a specialized PGx question catalog, the AI assistant showed high efficacy in addressing user queries. Compared with OpenAI’s ChatGPT 3.5, it demonstrated better performance, especially in provider-specific queries requiring specialized data and citations. Key areas for improvement include enhancing accuracy, relevancy, and representative language in responses.

Discussion

The integration of context-aware GPT-4 with RAG significantly enhanced the AI assistant’s utility. RAG’s ability to incorporate domain-specific CPIC data, including recent literature, proved beneficial. Challenges persist, such as the need for specialized genetic/PGx models to improve accuracy and relevancy and addressing ethical, regulatory, and safety concerns.

Conclusion

This study underscores generative AI’s potential for transforming healthcare provider support and patient accessibility to complex pharmacogenomic information. While careful implementation of large language models like GPT-4 is necessary, it is clear that they can substantially improve understanding of pharmacogenomic data. With further development, these tools could augment healthcare expertise, provider productivity, and the delivery of equitable, patient-centered healthcare services.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicinePharmacogeneticsHumansArtificial IntelligenceKnowledge BasesInformation Storage and RetrievalPharmacogenomic Testing

Stichwörter der Autor:innen

AI assistantOpenAI GPT-4generative AIlarge language modelspharmacogenomic testingretrieval-augmented generation

Autor:innen und Institutionen

  • Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, United States.
  • Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States.
  • Sections of Cardiology and Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX, United States.
  • School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, United States.
  • Department of Pharmacy, UPMC Presbyterian-Shadyside Hospital, Pittsburgh, PA, United States.
  • Institute for Precision Medicine, UPMC/University of Pittsburgh, Pittsburgh, PA, United States.

ORCID-Profile: Mullai Murugan

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Murugan, M., Yuan, B., Venner, E., Ballantyne, C. M., Robinson, K. M., Coons, J. C., Wang, L., Empey, P. E., & Gibbs, R. A. (2024). Empowering personalized pharmacogenomics with generative AI solutions. Journal of the American Medical Informatics Association, 31(6), 1356-1366. https://doi.org/10.1093/jamia/ocae039

Vancouver

Murugan M, Yuan B, Venner E, Ballantyne CM, Robinson KM, Coons JC, et al. Empowering personalized pharmacogenomics with generative AI solutions. Journal of the American Medical Informatics Association. 2024;31(6):1356-1366. doi:10.1093/jamia/ocae039

BibTeX
@article{Murugan2024,
  author = {Murugan, Mullai and Yuan, Bo and Venner, Eric and Ballantyne, Christie M and Robinson, Katherine M and Coons, James C and Wang, Liwen and Empey, Philip E and Gibbs, Richard A},
  title = {Empowering personalized pharmacogenomics with generative AI solutions},
  journal = {Journal of the American Medical Informatics Association},
  year = {2024},
  volume = {31},
  number = {6},
  pages = {1356--1366},
  doi = {10.1093/jamia/ocae039}
}
Kostenlos starten →